Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-04-14 | John H. Johnson, Director (64) Mr. Johnson has served as a member of our Board of Directors since July 2021. ... Messrs. Johnson (Chairman), and Levine and Ms. Wendell and Dr. Gold are members of the Audit Committee. ... Mr. Johnson currently serves as Chairman of the Audit Committee. |
| 2023-07-07 | None |
| 2024-04-24 | John H. Johnson has served as a member of our Board of Directors since July 2021. Mr. Johnson currently serves as Chief Executive Officer and Board Director of Reaction Biology. Mr. Johnson currently on the Board of Directors of Xeris and Verastem. Mr. Johnson’s qualifications include considerable leadership experience and specific knowledge of the healthcare industry. |
Data sourced from SEC filings. Last updated: 2025-12-07